Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Asia Pacific Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
... Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells) The Asia Pacific organoids market is expected to grow from US$ 419.14 million ... Read More
-
Middle East & Africa Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
... Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells) The Middle East & Africa organoids market is expected to grow ... Read More
-
South America Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
... Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells) The South America organoids market is expected to grow from US$ 160.44 million ... Read More
-
North America Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
... Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells) The North America organoids market is expected to grow from US$ 1,357.19 million ... Read More
-
Europe Organoids Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells)
... Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), and Source (Pluripotent Stem Cells and Organ-specific Adult Stem Cells) The Europe organoids market is expected to grow from US$ 1,018.12 million in 2023 ... Read More
-
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... diagnosed prevalent cases of DLBCL are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for DLBCL. Rituximab in combination with chemotherapy is the standard treatment for DLBCL in the first-line setting. ... Read More
-
Global Markets for Artificial Intelligence in Drug Discovery
... in drug discovery using data from 2020, estimates from 2021, projections of compound annual growth rates through 2028 (i.e., the forecast period 2023-2028), and information about regional markets of AI in drug discovery. This report ... Read More
-
Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors Such As increasing prevalence of ... Read More
-
Lab Automation Market Assessment, By Product [Automated Workstations, Automated Integrated Workstations, Pipetting Systems, Reagent Dispensers, Microplate Washers, Multimode Microplate Readers, Filter Based, Monochromator Based, Hybrid, Single Mode Microplate Reader, Fluorescence, Absorbance, Luminescence, Off the Shelf Automated Work Cells, Software, Robotic System, Automated Storage Retrieval System, Other Lab Automation Equipment] By Application [Drug Discovery, Diagnostics, Genomic Solutions, Proteomics Solutions, Microbiology, Other Applications], By End User [Biotechnology and Pharmaceutical Companies, Hospital and Diagnostic Laboratories, Research and Academic Institutes, Forensic Laboratories, Environmental and Testing Laboratories, Food and Beverage Industries], By Region, Opportunities and Forecast, 2016-2030F
... Automated Work Cells, Software, Robotic System, Automated Storage Retrieval System, Other Lab Automation Equipment] By Application [Drug Discovery, Diagnostics, Genomic Solutions, Proteomics Solutions, Microbiology, Other Applications], By End User [Biotechnology and Pharmaceutical Companies, Hospital and ... Read More
-
Global Hematological Malignancies Emerging Therapeutics Market 2023
... in 2022 and is expected to reach $23.27 billion by 2029. Pharmaceutical companies' interest in developing therapies for hematological malignancies has driven market advancements. Monoclonal antibodies have been widely used, but there is an anticipated ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... million diagnosed prevalent cases of DN are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for DN. Among the marketed DN drugs available, most of the drugs are enzyme inhibitors, followed ... Read More
-
Global Explainable AI Market Size Study & Forecast, by Component (Solution, Services), By Deployment (Cloud, On-Premises), By Application (Fraud and anomaly detection, Drug discovery & diagnostics, Predictive maintenance, Supply chain management, Identity and access management), By End-use (Healthcare, BFSI, Aerospace & Defense, Retail and e-commerce, IT & telecommunication, Others), and Regional Analysis, 2023-2030
... By End-use (Healthcare, BFSI, Aerospace & Defense, Retail and e-commerce, IT & telecommunication, Others), and Regional Analysis, 2023-2030 Global Explainable AI Market is valued at approximately USD 5.49 billion in 2022 and is anticipated to ... Read More
-
Oman Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... million by 2028, at a CAGR of 6.61% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 258 million by 2027. The COVID-19 pandemic positively impacted the ... Read More
-
United States Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 37.69 billion by 2028, at a CAGR of 3.70% during the forecast period (2023-2028). COVID-19 has carved an especially fatal route through the 1 in 10 diabetics in the United States, including ... Read More
-
Brazil Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.94 billion by 2028, growing at a CAGR of 4.10% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older ... Read More
-
Iran Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 386.81 million by 2028, growing at a CAGR of 3.90% during the forecast period (2023-2028). Inadequate preventive measures interrupted traditional methods of relationship with the patient, medication shortages, disruption of routine diabetic ... Read More
-
Spain Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.45 billion by 2028, growing at a CAGR of 4.50% during the forecast period (2023-2028). Spain has According to WHO, 102,258,825 vaccination doses have been delivered as of June 25, 2022. Regardless ... Read More
-
Australia Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 939.07 million by 2028, growing at a CAGR of 3.60% during the forecast period (2023-2028). The COVID-19 epidemic boosted the expansion of the Australia Diabetes Care Drugs Market. Diabetes patients infected with ... Read More
-
Russia Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 4.50% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Russia has ... Read More
-
China Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 13.73 billion by 2028, growing at a CAGR of 2.70% during the forecast period (2023-2028). According to WHO, 20% of persons with diabetes and diabetes-related disorders died in China in January 2020 ... Read More
-
Egypt Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... million by 2028, at a CAGR of 3% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 730 million by 2027. The COVID-19 pandemic positively impacted the ... Read More
-
United Kingdom (UK) Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.20 billion by 2028, at a CAGR of 3.05% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the United Kingdom's diabetes drugs market. According to The British Diabetic ... Read More
-
South Korea Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.18 billion by 2028, growing at a CAGR of 3.70% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 1 billion by 2027. The ... Read More
-
Saudi Arabia Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2.65 billion by 2028, at a CAGR of 9% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 2.8 billion by 2027. The COVID-19 pandemic positively ... Read More
-
South Africa Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 375.50 million by 2028, at a CAGR of 2.46% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 380 million by 2027. The COVID-19 pandemic positively ... Read More
Research Assistance
